header logo image


Page 1,296«..1020..1,2951,2961,2971,298..1,3101,320..»

Treatment for Spinal Cord Injury with Stem Cells Therapy – Video

July 10th, 2013 10:45 am


Treatment for Spinal Cord Injury with Stem Cells Therapy
Treatment for Spinal Cord Injury with Stem Cells Therapy, successfully results , after receiving the Stem Cells Treatment patient is regaining leg feeling and capable to perform initial movements...

By: enjades

Read more from the original source:
Treatment for Spinal Cord Injury with Stem Cells Therapy - Video

Read More...

Stem Cells For Spinal Cord Injury successfully results – Video

July 10th, 2013 10:45 am


Stem Cells For Spinal Cord Injury successfully results
Stem Cells For Spinal Cord Injury successfully results, Performed by NeuroSurgeon Dr. Luis Jorge Quintero, patient was treated with Stem Cells Therapy and ge...

By: enjades

See more here:
Stem Cells For Spinal Cord Injury successfully results - Video

Read More...

Jeunesse® Global Revolutionary Anti Aging Skin Care with Stem Cells – Video

July 10th, 2013 10:45 am


Jeunesse® Global Revolutionary Anti Aging Skin Care with Stem Cells
Info / Join Online : http://www.Network888.JeunesseGlobal.com At Jeunesse®, we #39;ve turned science fiction into science fact. We #39;re redefining youth and shifti...

By: JeunesseNetwork

Visit link:
Jeunesse® Global Revolutionary Anti Aging Skin Care with Stem Cells - Video

Read More...

Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. Part 2 – Video

July 9th, 2013 12:49 pm


Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. Part 2
Improvement seen in just 3 months after Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy...

By: Neurogen Brain and Spine Institute

See the original post:
Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. Part 2 - Video

Read More...

Stem cell therapy future of medicine?

July 9th, 2013 12:49 pm

by Rappler.com Posted on 07/09/2013 9:42 PM |Updated 07/09/2013 10:20 PM

MANILA, Philippines - Everyone is talking about stem cell therapy. But scammers and swindlers are also taking advantage of the fad, prompting the Health Department to step in. Buena Bernal reports.

Its the new medical buzzword in the Philippines. Stem cell therapy is a procedure which uses repair cells found in the body to replace old cells. Dr Florencio Lucero started doing the procedure 6 years ago.

DR FLORENCIO LUCERO, STEM CELL TRANSPLANT SURGEON: Stem cells can help degenerative diseases. Some people who have serious illnesses, and they cannot find any solution to their condition, they seek this kind of treatment, because it can improve their condition. But not a cure. It cannot cure.

Stroke survivor Pilar Vasquez says she felt energized after undergoing the treatment.

PILAR VASQUEZ, STEM CELL TRANSPLANT PATIENT: Stem cell is very good. I did not feel pain or what. Everything is very good. Before, I dont talk. Now, I always talk. Thats a very good difference, because now they say, Ay si Mommy, ang galing galing niyan, parating nagsasalita!

But stem cell therapy became controversial after 3 government officials allegedly died from the treatment, while another official filed charges against his German doctor for his botched treatment last year. Food and Drug Administration director Dr. Kenneth Hartigan Go says right now, stem cell therapy is allowed but under investigation.

DR KENNETH HARTIGAN-GO, DIRECTOR, FOOD AND DRUG ADMINISTRATION: We are keeping an objective mind and saying, okay, if this is investigational, go ahead. And then we have to see outcome, say, within a period of a time whether the product actually works or not.

The Department of Health cautions the public from engaging in prohibited forms of the treatment -- those that are performed outside accredited facilities and those that source stem cells from human embryos. Health Secretary Enrique Ona says he does not want to stifle the innovation but there must be regulation.

View original post here:
Stem cell therapy future of medicine?

Read More...

Anti aging + Multiple Disorders Treatment using stem cells – Video

July 9th, 2013 6:45 am


Anti aging + Multiple Disorders Treatment using stem cells
THE ADVANTAGES Of A Fat Stem Cell Anti-Aging Treatment Stem Cells from your own body are used No chemicals or drugs are needed Better breathing and sleeping pattern. Energy levels restored...

By: StemRx BioScience

See the rest here:
Anti aging + Multiple Disorders Treatment using stem cells - Video

Read More...

Cerebral Palsy treatment using stem cells – Video

July 9th, 2013 6:45 am


Cerebral Palsy treatment using stem cells
Cerebral Palsy can be treated with stem cell therapy. know more at http://www.stemrx.in.

By: StemRx BioScience

Originally posted here:
Cerebral Palsy treatment using stem cells - Video

Read More...

Testimonial: Heart Attack, Kidney Failure, Hyperuricemia (Mr. Say Bee) – Video

July 9th, 2013 6:44 am


Testimonial: Heart Attack, Kidney Failure, Hyperuricemia (Mr. Say Bee)
Follow me on YouTube and Facebook for more updates and information! Contact Evelyn @ +65 8699 5092 Facebook: Purtier - Live Stem Cell Therapy.

By: PurtierSG

Read the original post:
Testimonial: Heart Attack, Kidney Failure, Hyperuricemia (Mr. Say Bee) - Video

Read More...

Purtier NZ Live Stem Cell Therapy presented by Dr Chen – Video

July 9th, 2013 6:43 am


Purtier NZ Live Stem Cell Therapy presented by Dr Chen
For Live demo and discussion: Call John 90036287 / Daphne 91455217.

By: petty joy

Visit link:
Purtier NZ Live Stem Cell Therapy presented by Dr Chen - Video

Read More...

Michael – The Alliance for the Advancement of Adult Stem Cell Therapy and Research – Video

July 8th, 2013 5:46 am


Michael - The Alliance for the Advancement of Adult Stem Cell Therapy and Research
The Alliance is here to assist people like Michael to receive adult stem cell treatment. Your donation WILL make a difference. If you #39;d like your donation to go to a specific person just mention...

By: TheStemCellAlliance

Read the rest here:
Michael - The Alliance for the Advancement of Adult Stem Cell Therapy and Research - Video

Read More...

6 things you need to know about stem cell therapy

July 8th, 2013 5:46 am

by Buena Bernal Posted on 07/06/2013 9:06 PM |Updated 07/08/2013 2:15 PM

DOH ON STEM CELL. (Left) Health Secretary Enrique Ona and (right) FDA Director Kenneth Hartigan-Go talks to Rappler about stem cell therapy. Photos by Rappler/Naoki Mengua

MANILA, Philippines (UPDATED) Rappler talked to Department of Health (DOH) Secretary Enrique Ona and Food and Drug Administration (FDA) Director Kenneth Hartigan-Go to clarify the governments stance on stem cell therapy.

Stem cell therapy or regenerative medicine is a medical intervention that uses the bodys repair cells to substitute old cells. It is done for medical and aesthetic purposes that are still being investigated, according to the health secretary.

Asked why the treatment was allowed in the market despite no definitive curative and preventive benefits, FDA's Hartigan-Go said authorities never allowed the treatment to begin with.

Its just there. Now, the DOH under Secretary Ona's leadership took action," he said.

(READ: DOH: Stem cell therapy not yet proven to be curative)

On March 18, the DOH issued the rules and regulations for the accreditation of health facilities engaging in human stem cell and cell-based or cellular therapies in the Philippines.

The FDA has also released a circular on Monday, Jully 8, regarding the guidelines on registering stem cell-based products. The circular covers all products with a "claim, label, or poster" that says stem cells.

(READ: FDA Circular: Registration of Stem Cell-Based Products)

Read the original post:
6 things you need to know about stem cell therapy

Read More...

Scientists Create Liver From Stem Cells – Video

July 7th, 2013 8:44 pm


Scientists Create Liver From Stem Cells
Description: Researchers in Japan say they have grown a tiny human liver from pluripotent stem cells. Story: Japanese scientists have created a functional hu...

By: NTDTV

Go here to see the original:
Scientists Create Liver From Stem Cells - Video

Read More...

[NewsLife] CIDG: Stem cells suspect may have left the country – Video

July 7th, 2013 8:44 pm


[NewsLife] CIDG: Stem cells suspect may have left the country
NewsLife - CIDG: Stem cells suspect may have left the country (Reported By: Alvin Baltazar) - [July 5, 2013] For more news, visit: #9659;http://www.ptvnews.ph Download our mobile App. in your...

By: PTV PH

See the article here:
[NewsLife] CIDG: Stem cells suspect may have left the country - Video

Read More...

Questions you should ask to doctor for Alzheimer disease

July 7th, 2013 3:00 am

Alzheimer’s Disease is a critical health condition that cannot be defined in a specific way.It is a very common form of Dementia. Dementia in itself is not a disease. Rather, it is a group of symptoms that start occurring due to occurrence of some other disease or medical condition.Person suffering from Alzheimer’s Disease can face difficulty in remembering even the most recently happened events. This is the initial stage. The disease can lead to death of a person too! The disease starts to occur in people who have crossed 65 years of age or more. Those who get diagnosed with this difficult disease, a good doctor needs to be consulted at the earliest. There are certain questions that need to be placed before the doctor related to the disease. Some of the most important questions are listed below:

What is the usual course of the Alzheimer’s disease?

Life long.

What type of new treatments are available?

Since it is not a disease, there is no particular treatment available. However, some medicines are available but that too works at the early stages.

Are the drugs used to treat the AD symptoms effective?

Yes, at times and mostly during the early stages.

Does these drugs have any sort of side effects?

At time, yes. It can cause poor eyesight problem, gaining weight, as well itching problems.

Does the AD affects a person for the remaining part of his/her living days?

Yes, definitely.

What is the total time period for a person to act in a very normal way post Alzheimer’s diagnosis?

The first and middle stages are still OK with the patients. Although slight changes start taking place but still the behavior doesn’t get completely out of the mark. But, once the patient reaches advanced stage, scenarios tend to become more complicated.

Can a patient of Alzheimer’s Disease be a threat to other or themselves?

The Patient can be a real threat to him/herself. At advanced stage, the patient can even forget her/his own address, name, etc. Scenarios can get real complicated when the patient fails to identify his/her relatives, family members and friends.

Is home or nursing home the best place to take care of the person suffering from AD?

No, there is no such a thing. A lonely person with no one to take care of can stay best in a nursing home. But a person with good family and friends can easily stay in the home. Alzheimer’s is a not a disease but a syndrome that can be as deadly as any other disease. But, there is no specific treatment for it. So, there is no need to spend unnecessary money booking a bed in the nursing home.

What are the necessary precautions to take in order to make the home surroundings safe for someone who has been diagnosed with Alzheimer’s?

A clean surrounding can definitely help. The person suffering from AD should be kept stress free. The patient should have more interaction with family members and friends. However, by no means the patient should be made excited or furious. It can provide extra stress on the brain. This can cause some negative repercussions.

What are the best available support and services are available in the local area related to Alzheimer’s disease?

This is a very important question to ask the doctor. Remember, if local medicinal help can be availed, then much of worries are eliminated.

Is Alzheimer’s considered a hereditary disease?

Yes, definitely. But it is only a small part of the bigger process. AD can develop due to several factors, most important being strong stress.

Source:
http://www.biotechblog.org/entry/questions-doctor-alzheimer-disease/

Read More...

Music to your ears? Try a headphones implant like Rich Lee

July 7th, 2013 3:00 am

'Grinder' can listen to music player by wearing a loose wire coil around his neckDon't offer Rich Lee a pair of headphones to listen to music: he's already got a pair, even though you can't see them. They're implanted in his ears – a procedure carried out by a "body modification" expert.Now, by connecting his music player to a loose wire coil around his neck (which he can tuck under his shirt), Lee can listen to music without blocking out the outside world. The tiny magnets implanted invisibly in his outer ears pick up the signal and generate sound.But that's only the beginning. Lee, 34, who works as a salesman, intends to hook it up to an ultrasonic rangefinder – effectively giving himself bat-like echolocation. And he would like to have X-ray vision, super-strength, and anything else...

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

Source:
http://www.medworm.com/index.php?rid=7397462&cid=c_449_58_f&fid=36473&url=http%3A%2F%2Fwww.guardian.co.uk%2Ftechnology%2F2013%2Fjul%2F04%2Fheadphones-implanted-ear-grinder-rich-lee

Read More...

Challenge to WARF hESC Patents Cites Recent U.S. Supreme Court Decision

July 7th, 2013 3:00 am
Patents on human embryonic stem cells
are being challenged in a new legal filing that cites the recent U.S.
Supreme Court
decision that barred the patenting of human genes.
The stem cell case involves the
Wisconsin Alumni Research Foundation (WARF), which holds the patents on the
much-heralded work performed by Jamie Thomson  at the University of Wisconsin. The lawsuit was filed
by the Public Patent Foundation of New York City on behalf of
Consumer Watchdog, a nonprofit group in Santa Monica, Ca. Jeanne
Loring
, director of the Center for Regenerative Medicine at the
Scripps Research Institute, is also involved along with Alan
Trounson
, president of the California stem cell agency. The agency
itself is not a party.
This week's filing follows the
so-called Myriad decision last month by the nation's highest court which said,

“Myriad did not create anything. To
be sure, it found an important and useful gene, but separating that
gene from its surrounding genetic material is not an act of
invention.”

This week's stem cell suit said,

"WARF did not create or alter the
properties inherent in stem cells any more than Myriad created or
altered the genetic information encoded in the DNA it claimed.” 

The legal filing came in an appeal of
an earlier decision by the U.S. Patent Office. The Public Patent
Foundation, which was a successful party in the Myriad case, did the earlier legal work on the challenge to the WARF patents as well as this
week's appeal.
The appeal, prepared by Dan Ravicher,
said the WARF patents have "put a severe burden on taxpayer-funded
research in California.”
Trounson released a statement saying,

“We don't want to do anything that
gets in the way of finding treatments for some of the biggest killers
today, so we feel that all patients with all kinds of diseases
deserve to have access to these kinds of cells.”

Loring was quoted in a Consumer Watchdog press release as saying,

"Human embryonic stem cells hold
great promise for advancing human health, and no one has the ethical
right to own them.”

John M. Simpson of Consumer Watchdog
said,

 “The best course if WARF truly
cares about scientific advancement would be to
simply abandon these over-reaching patent claims.”

A story by Bradley Fikes in the San
Diego U-T
cited intellectual property attorney Lisa Haile of DLA
Piper
as saying,

“A successful use of the Myriad case
as a precedent for throwing out the foundation’s patent would open
the door to similar challenges in just about any biotech product
using material derived from life.”

WARF made no immediate comment.

Other stories on the WARF challenge
appeared in the Milwaukee JournalGenomeweb and the LaCross Tribune. 

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/LuLuZLLjyDo/challenge-to-warf-hesc-patents-cites.html

Read More...

California Legislation, Human Egg Sales and Profits

July 7th, 2013 3:00 am

California legislation to allow women
to be paid for their eggs for scientific research is sailing toward
final passage literally swaddled in motherhood and apple pie
arguments. Missing from the debate is a key reason behind
the bill – building profits for what some call the “baby
business.”

The legislation is touted as providing
equal treatment for women, permitting them to be paid for supplying
eggs for stem cell and other research, much as men are paid for
sperm. It also would put women who sell their eggs for research on an
equal economic footing with women who sell their eggs for fertility
treatments, which is currently permitted under state law. Payments to
those women range from an average of $9,000 to as much as $50,000,
according to a legislative analysis of the bill.

 Assemblywoman Susan Bonillla,
D-Concord, author of the bill(AB926), says,

“It is time to let women, just as any
other research subject, make an informed decision as to
participation, and justly compensate them for doing so.”

She also says that the ban on payments
has had serious impact on fertility research. In a legislative bill analysis, she says,

“It has led to a de facto prohibition
on women’s reproductive research in California, adversely
impacting the same women that the ban intended to protect. With few
oocytes donated, fertility research and fertility preservation
research has been at a standstill. This greatly affects women
suffering from fertility issues and women facing cancer who would
like to preserve their oocytes.”

Bonilla is carrying the measure on
behalf of an industry group, the American Society for Reproductive Medicine of Alabama. The fertility or baby business, which is largely
unregulated, brings in about $5 billion annually in the United
States from something like 500 clinics. It has grown rapidly over the
last couple of decades, but is likely heading for a soft spot.
Little public information is available
on the Internet discussing the industry's economic challenges.
However, demographic studies show that the size of the key market
for fertility services is stagnating. A 2012 report by the federal
government projects that the number of women in the 35 to 44 age
group, prime consumers of fertility services, is likely to grow only
0.5 percent from 2010 to 2020. And since that forecast was made, the
Census Bureau has downgraded its projections for total population
growth.
Bonilla's legislation effectively adds
a new, potential revenue stream for the industry. Fertility clinics
would be able to buy the eggs and then resell them to researchers,
adding premiums for eggs from women with special characteristics. The bill would also add a tool for bringing down the cost of fertility
treatments, which can run as much as $12,000 to $17,000 a round or
more and require several rounds, according to the NIH. Clinics could discount those prices for some women, bringing in
new customers, if they agree to authorize the use of excess eggs for
scientific research.
None of this appears necessarily
pernicious. What is pernicious is the absence of discussion of the
economics of the legislation. Without a full understanding of all
that is at stake, including economic issues and motivations,
legislators, the governor and the public are hard-pressed to make
good decisions about a significant change in California law.
Opponents of the legislation have
raised serious questions about the treatment of women by fertility
clinics, noting that the bill would turn egg providers into “vendors”
– not patients of the clinics. The Center for Genetics and Society
in Berkeley has captured the arguments in opposition including
testimony before a Senate committee hearing early in June.
Jennifer Schneider, a physician who
lost a 31-year-old daughter to cancer seven years after the younger
woman sold her eggs three times, told lawmakers,

“Unlike infertile women who are
considered patients, egg donors are treated as vendors( (her italics).
When they walk out of the IVF clinic, no one keeps track of them. 
My daughter’s death was not reported. The long-term risks of egg
donation are unknown."

Sindy Wei, a former egg provider and
now a physician with a Ph.D. in biology, testified that she wound up
in an intensive care unit after 60 eggs were extracted from her in
2001. She said,

“I fear that cases like mine are
buried deep by fertility centers concerned about their image. An
industry thriving on profits and reputation has little incentive to
report adverse events, or protect the health and medical rights of
donors.”

Where is the $3 billion California stem
cell agency on all this? The agency has not taken a position on the
bill nor have any major research organizations. The measure does not
change the law affecting agency-funded research, which bans the use of
compensation for eggs in its research. Enactment of the law, however, would
create a two-tier stem cell research standard in California, one for
scientists not constrained by the payment ban and another for those
who could use the full range of research tools. Some stem cell
researchers may well think that they have become disadvantaged as a
result.

(Editor's note: An earlier version of this article said the IVF business generated $4 billion in revenues annually. More recent estimates place it at $5 billion.)

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/0ke5iLQwGdA/california-legislation-human-egg-sales.html

Read More...

Music to your ears? Try a headphones implant like Rich Lee

July 7th, 2013 2:57 am

'Grinder' can listen to music player by wearing a loose wire coil around his neckDon't offer Rich Lee a pair of headphones to listen to music: he's already got a pair, even though you can't see them. They're implanted in his ears – a procedure carried out by a "body modification" expert.Now, by connecting his music player to a loose wire coil around his neck (which he can tuck under his shirt), Lee can listen to music without blocking out the outside world. The tiny magnets implanted invisibly in his outer ears pick up the signal and generate sound.But that's only the beginning. Lee, 34, who works as a salesman, intends to hook it up to an ultrasonic rangefinder – effectively giving himself bat-like echolocation. And he would like to have X-ray vision, super-strength, and anything else...

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

Source:
http://www.medworm.com/index.php?rid=7397462&cid=c_449_58_f&fid=36473&url=http%3A%2F%2Fwww.guardian.co.uk%2Ftechnology%2F2013%2Fjul%2F04%2Fheadphones-implanted-ear-grinder-rich-lee

Read More...

Challenge to WARF hESC Patents Cites Recent U.S. Supreme Court Decision

July 7th, 2013 2:57 am
Patents on human embryonic stem cells
are being challenged in a new legal filing that cites the recent U.S.
Supreme Court
decision that barred the patenting of human genes.
The stem cell case involves the
Wisconsin Alumni Research Foundation (WARF), which holds the patents on the
much-heralded work performed by Jamie Thomson  at the University of Wisconsin. The lawsuit was filed
by the Public Patent Foundation of New York City on behalf of
Consumer Watchdog, a nonprofit group in Santa Monica, Ca. Jeanne
Loring
, director of the Center for Regenerative Medicine at the
Scripps Research Institute, is also involved along with Alan
Trounson
, president of the California stem cell agency. The agency
itself is not a party.
This week's filing follows the
so-called Myriad decision last month by the nation's highest court which said,

“Myriad did not create anything. To
be sure, it found an important and useful gene, but separating that
gene from its surrounding genetic material is not an act of
invention.”

This week's stem cell suit said,

"WARF did not create or alter the
properties inherent in stem cells any more than Myriad created or
altered the genetic information encoded in the DNA it claimed.” 

The legal filing came in an appeal of
an earlier decision by the U.S. Patent Office. The Public Patent
Foundation, which was a successful party in the Myriad case, did the earlier legal work on the challenge to the WARF patents as well as this
week's appeal.
The appeal, prepared by Dan Ravicher,
said the WARF patents have "put a severe burden on taxpayer-funded
research in California.”
Trounson released a statement saying,

“We don't want to do anything that
gets in the way of finding treatments for some of the biggest killers
today, so we feel that all patients with all kinds of diseases
deserve to have access to these kinds of cells.”

Loring was quoted in a Consumer Watchdog press release as saying,

"Human embryonic stem cells hold
great promise for advancing human health, and no one has the ethical
right to own them.”

John M. Simpson of Consumer Watchdog
said,

 “The best course if WARF truly
cares about scientific advancement would be to
simply abandon these over-reaching patent claims.”

A story by Bradley Fikes in the San
Diego U-T
cited intellectual property attorney Lisa Haile of DLA
Piper
as saying,

“A successful use of the Myriad case
as a precedent for throwing out the foundation’s patent would open
the door to similar challenges in just about any biotech product
using material derived from life.”

WARF made no immediate comment.

Other stories on the WARF challenge
appeared in the Milwaukee JournalGenomeweb and the LaCross Tribune. 

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/LuLuZLLjyDo/challenge-to-warf-hesc-patents-cites.html

Read More...

California Legislation, Human Egg Sales and Profits

July 7th, 2013 2:57 am

California legislation to allow women
to be paid for their eggs for scientific research is sailing toward
final passage literally swaddled in motherhood and apple pie
arguments. Missing from the debate is a key reason behind
the bill – building profits for what some call the “baby
business.”

The legislation is touted as providing
equal treatment for women, permitting them to be paid for supplying
eggs for stem cell and other research, much as men are paid for
sperm. It also would put women who sell their eggs for research on an
equal economic footing with women who sell their eggs for fertility
treatments, which is currently permitted under state law. Payments to
those women range from an average of $9,000 to as much as $50,000,
according to a legislative analysis of the bill.

 Assemblywoman Susan Bonillla,
D-Concord, author of the bill(AB926), says,

“It is time to let women, just as any
other research subject, make an informed decision as to
participation, and justly compensate them for doing so.”

She also says that the ban on payments
has had serious impact on fertility research. In a legislative bill analysis, she says,

“It has led to a de facto prohibition
on women’s reproductive research in California, adversely
impacting the same women that the ban intended to protect. With few
oocytes donated, fertility research and fertility preservation
research has been at a standstill. This greatly affects women
suffering from fertility issues and women facing cancer who would
like to preserve their oocytes.”

Bonilla is carrying the measure on
behalf of an industry group, the American Society for Reproductive Medicine of Alabama. The fertility or baby business, which is largely
unregulated, brings in about $5 billion annually in the United
States from something like 500 clinics. It has grown rapidly over the
last couple of decades, but is likely heading for a soft spot.
Little public information is available
on the Internet discussing the industry's economic challenges.
However, demographic studies show that the size of the key market
for fertility services is stagnating. A 2012 report by the federal
government projects that the number of women in the 35 to 44 age
group, prime consumers of fertility services, is likely to grow only
0.5 percent from 2010 to 2020. And since that forecast was made, the
Census Bureau has downgraded its projections for total population
growth.
Bonilla's legislation effectively adds
a new, potential revenue stream for the industry. Fertility clinics
would be able to buy the eggs and then resell them to researchers,
adding premiums for eggs from women with special characteristics. The bill would also add a tool for bringing down the cost of fertility
treatments, which can run as much as $12,000 to $17,000 a round or
more and require several rounds, according to the NIH. Clinics could discount those prices for some women, bringing in
new customers, if they agree to authorize the use of excess eggs for
scientific research.
None of this appears necessarily
pernicious. What is pernicious is the absence of discussion of the
economics of the legislation. Without a full understanding of all
that is at stake, including economic issues and motivations,
legislators, the governor and the public are hard-pressed to make
good decisions about a significant change in California law.
Opponents of the legislation have
raised serious questions about the treatment of women by fertility
clinics, noting that the bill would turn egg providers into “vendors”
– not patients of the clinics. The Center for Genetics and Society
in Berkeley has captured the arguments in opposition including
testimony before a Senate committee hearing early in June.
Jennifer Schneider, a physician who
lost a 31-year-old daughter to cancer seven years after the younger
woman sold her eggs three times, told lawmakers,

“Unlike infertile women who are
considered patients, egg donors are treated as vendors( (her italics).
When they walk out of the IVF clinic, no one keeps track of them. 
My daughter’s death was not reported. The long-term risks of egg
donation are unknown."

Sindy Wei, a former egg provider and
now a physician with a Ph.D. in biology, testified that she wound up
in an intensive care unit after 60 eggs were extracted from her in
2001. She said,

“I fear that cases like mine are
buried deep by fertility centers concerned about their image. An
industry thriving on profits and reputation has little incentive to
report adverse events, or protect the health and medical rights of
donors.”

Where is the $3 billion California stem
cell agency on all this? The agency has not taken a position on the
bill nor have any major research organizations. The measure does not
change the law affecting agency-funded research, which bans the use of
compensation for eggs in its research. Enactment of the law, however, would
create a two-tier stem cell research standard in California, one for
scientists not constrained by the payment ban and another for those
who could use the full range of research tools. Some stem cell
researchers may well think that they have become disadvantaged as a
result.

(Editor's note: An earlier version of this article said the IVF business generated $4 billion in revenues annually. More recent estimates place it at $5 billion.)

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/0ke5iLQwGdA/california-legislation-human-egg-sales.html

Read More...

Page 1,296«..1020..1,2951,2961,2971,298..1,3101,320..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick